TBP and spinocerebellar ataxia type 17: A study by Huang et al. [62] investigated the positive effects of EGb 761, a standardised extract of Ginkgo biloba, in in vitro models of SCA17 using HEK 293 and SH-SY5Y cells expressing mutant TATA-box binding protein (TBP), and an in vivo transgenic mouse model overexpressing TBP.